A neural collaborative filtering method for identifying miRNA-disease associations

Predicting associations between CircRNA and diseases through structure-aware graph transformer and path-integral convolution

A series of biological experiments has demonstrated that circular RNAs play a crucial regulatory role in cellular processes and may be potentially associated with diseases. Uncovering these connections helps in understanding potential disease mechanisms and advancing the development of treatment strategies. However, in biology, traditional experiments face limitations in terms of efficiency and cost, especially when enumerating possible associations. To address these limitations, several computational methods have been proposed, but existing methods only measure from a nodal perspective and cannot capture structural similarities between edges. In this study, we introduce an advanced computational method called SATPIC2CD for analyzing potential associations between circular RNAs and diseases. Specifically, we first employ an Structure-Aware Graph Transformer (SAT), which extracts five predefined metapath representations before calculating attention. This adaptive network integrates structural information into the original self-attention by aggregating information within and between paths. Subsequently, we use Path Integral Convolutional Networks (PACN) to integrate feature information for all path weights between two nodes. Afterward, we complement the network node features with feature loss and feature smoothing using Gated Recurrent Units (GRU) and node centrality. Finally, a Multi-Layer Perceptron (MLP) is employed to obtain the ultimate prediction scores for each circular RNA-disease pair. SATPIC2CD performs remarkably well, with an accuracy of up to 0.9715 measured by the Area Under the Curve (AUC) in a 5-fold cross-validation, surpassing other comparative models. Case studies further emphasize the high precision of our method in identifying circular RNA-disease associations, laying a solid foundation for guiding future biological research efforts.

E-commerce recommender system based on improved K-means commodity information management model

Since the start of the 21st century, there has been a rapid development of internet technology, causing electronic computers and smartphones to become increasingly popular. The e-commerce industry also experiences quick development. However, the recommendation technology of e-commerce progresses slowly, hindering it from keeping up with the changing times. To enhance the efficiency and accuracy of e-commerce recommender systems, this research introduces an e-commerce recommender system that utilizes an enhanced K-means clustering algorithm to manage commodity information. This method combines the K-means algorithm with a genetic algorithm by encoding the genetic algorithm, setting the initial population, defining the fitness function, and configuring other parameters. The results of the test indicated that the K-mean clustering algorithm and fuzzy C-mean algorithm had a recommendation accuracy of 87.9 % and 84.8 % respectively under the test dataset. The highest recommendation accuracy was observed from the improved K-mean clustering algorithm, which was 91.1 %. The convergence rate of the improved K-mean clustering algorithm was faster by 44 % compared to the traditional K-mean clustering algorithm and 73 % quicker than the fuzzy C-mean algorithm. The study's findings demonstrate that the refined K-means clustering algorithm greatly enhances the recommendation proficiency and precision of the e-commerce recommendation system, in comparison to other comparable algorithms. This research can potentially advance the e-commerce industry and stimulate its growth.

CFNCM: Collaborative filtering neighborhood-based model for predicting miRNA-disease associations

MicroRNAs have a significant role in the emergence of various human disorders. Consequently, it is essential to understand the existing interactions between miRNAs and diseases, as this will help scientists better study and comprehend the diseases' biological mechanisms. Findings can be employed as biomarkers or drug targets to advance the detection, diagnosis, and treatment of complex human disorders by foretelling possible disease-related miRNAs. This study proposed a computational model for predicting potential miRNA-disease associations called the Collaborative Filtering Neighborhood-based Classification Model (CFNCM), in light of the shortcomings of conventional and biological experiments, which are expensive and time-consuming. The model generated integrated miRNA and disease similarity matrices using the validated associations and miRNA and disease similarity information and used them as the input features for CFNCM. To produce class labels, we first determined the association scores for brand-new pairs using user-based collaborative filtering. With zero as the threshold, the associations with scores >0 were labelled 1, indicating a potential positive association, otherwise, it is marked as 0. Then, we developed classification models using various machine-learning algorithms. By comparison, we discovered that the support vector machine (SVM) produced the best AUC of 0.96 with 10-fold cross-validation through the GridSearchCV technique for identifying optimal parameter values. In addition, the models were evaluated and verified by analyzing the top 50 breast and lung neoplasms-related miRNAs, of which 46 and 47 associations were verified in two authoritative databases, dbDEMC and miR2Disease.

Prediction of miRNA-Disease Associations by Cascade Forest Model Based on Stacked Autoencoder

Numerous pieces of evidence have indicated that microRNA (miRNA) plays a crucial role in a series of significant biological processes and is closely related to complex disease. However, the traditional biological experimental methods used to verify disease-related miRNAs are inefficient and expensive. Thus, it is necessary to design some excellent approaches to improve efficiency. In this work, a novel method (CFSAEMDA) is proposed for the prediction of unknown miRNA-disease associations (MDAs). Specifically, we first capture the interactive features of miRNA and disease by integrating multi-source information. Then, the stacked autoencoder is applied for obtaining the underlying feature representation. Finally, the modified cascade forest model is employed to complete the final prediction. The experimental results present that the AUC value obtained by our method is 97.67%. The performance of CFSAEMDA is superior to several of the latest methods. In addition, case studies conducted on lung neoplasms, breast neoplasms and hepatocellular carcinoma further show that the CFSAEMDA method may be regarded as a utility approach to infer unknown disease-miRNA relationships.

MLRDFM: a multi-view Laplacian regularized DeepFM model for predicting miRNA-disease associations

MOTIVATION

MicroRNAs (miRNAs), as critical regulators, are involved in various fundamental and vital biological processes, and their abnormalities are closely related to human diseases. Predicting disease-related miRNAs is beneficial to uncovering new biomarkers for the prevention, detection, prognosis, diagnosis and treatment of complex diseases.

RESULTS

In this study, we propose a multi-view Laplacian regularized deep factorization machine (DeepFM) model, MLRDFM, to predict novel miRNA-disease associations while improving the standard DeepFM. Specifically, MLRDFM improves DeepFM from two aspects: first, MLRDFM takes the relationships among items into consideration by regularizing their embedding features via their similarity-based Laplacians. In this study, miRNA Laplacian regularization integrates four types of miRNA similarity, while disease Laplacian regularization integrates two types of disease similarity. Second, to judiciously train our model, Laplacian eigenmaps are utilized to initialize the weights in the dense embedding layer. The experimental results on the latest HMDD v3.2 dataset show that MLRDFM improves the performance and reduces the overfitting phenomenon of DeepFM. Besides, MLRDFM is greatly superior to the state-of-the-art models in miRNA-disease association prediction in terms of different evaluation metrics with the 5-fold cross-validation. Furthermore, case studies further demonstrate the effectiveness of MLRDFM.

A miRNA-Disease Association Identification Method Based on Reliable Negative Sample Selection and Improved Single-Hidden Layer Feedforward Neural Network

miRNAs are a category of important endogenous non-coding small RNAs and are ubiquitous in eukaryotes. They are widely involved in the regulatory process of post-transcriptional gene expression and play a critical part in the development of human diseases. By utilizing recent advancements in big data technology, using bioinformatics methods to identify causative miRNA becomes a hot spot. In this paper, a method called RNSSLFN is proposed to identify the miRNA-disease associations by reliable negative sample selection and an improved single-hidden layer feedforward neural network (SLFN). It involves, firstly, obtaining integrated similarity for miRNAs and diseases; next, selecting reliable negative samples from unknown miRNA-disease associations via distinguishing up-regulated or down-regulated miRNAs; then, introducing an improved SLFN to solve the prediction task. The experimental results on the latest data sets HMDD v3.2 and the framework of 5-fold cross-validation (CV) show that the average AUC and AUPR of RNSSLFN achieve 0.9316 and 0.9065 m, respectively, which are superior to the other three state-of-the-art methods. Furthermore, in the case studies of 10 common cancers, more than 70% of the top 30 predicted miRNA-disease association pairs are verified in the databases, which further confirms the reliability and effectiveness of the RNSSLFN model. Generally, RNSSLFN in predicting miRNA-disease associations has prodigious potential and extensive foreground.

Hierarchical graph attention network for miRNA-disease association prediction

Many biological studies show that the mutation and abnormal expression of microRNAs (miRNAs) could cause a variety of diseases. As an important biomarker for disease diagnosis, miRNA is helpful to understand pathogenesis, and could promote the identification, diagnosis and treatment of diseases. However, the pathogenic mechanism how miRNAs affect these diseases has not been fully understood. Therefore, predicting the potential miRNA-disease associations is of great importance for the development of clinical medicine and drug research. In this study, we proposed a novel deep learning model based on hierarchical graph attention network for predicting miRNA-disease associations (HGANMDA). Firstly, we constructed a miRNA-disease-lncRNA heterogeneous graph based on known miRNA-disease associations, miRNA-lncRNA associations and disease-lncRNA associations. Secondly, the node-layer attention was applied to learn the importance of neighbor nodes based on different meta-paths. Thirdly, the semantic-layer attention was applied to learn the importance of different meta-paths. Finally, a bilinear decoder was employed to reconstruct the connections between miRNAs and diseases. The extensive experimental results indicated that our model achieved good performance and satisfactory results in predicting miRNA-disease associations.

A deep matrix factorization framework for identifying underlying tissue-specific patterns of DCE-MRI: applications for molecular subtype classification in breast cancer

Objective.Breast cancer is heterogeneous in that different angiogenesis and blood flow characteristics could be present within a tumor. The pixel kinetics of dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) can assume several distinct signal patterns related to specific tissue characteristics. Identification of the latent, tissue-specific dynamic patterns of intratumor heterogeneity can shed light on the biological mechanisms underlying the heterogeneity of tumors.Approach.To mine this information, we propose a deep matrix factorization-based dynamic decomposition (DMFDE) model specifically designed according to DCE-MRI characteristics. The time-series imaging data were decomposed into tissue-specific dynamic patterns and their corresponding proportion maps. The image pixel matrix and the reference matrix of population-level kinetics obtained by clustering the dynamic signals were used as the inputs. Two multilayer neural network branches were designed to collaboratively project the input matrix into a latent dynamic pattern and a dynamic proportion matrix, which was justified using simulated data. Clinical implications of DMFDE were assessed by radiomics analysis of proportion maps obtained from the tumor/parenchyma region for classifying the luminal A subtype.Main results.The decomposition performance of DMFDE was evaluated by the root mean square error and was shown to be better than that of the conventional convex analysis of mixtures (CAM) method. The predictive model withK = 3, 4, and 5 dynamic proportion maps generated AUC values of 0.780, 0.786 and 0.790, respectively, in distinguishing between luminal A and nonluminal A tumors, which are better than the CAM method (AUC = 0.726). The combination of statistical features from images with different proportion maps has the highest prediction value (AUC = 0.813), which is significantly higher than that based on CAM.Conclusion.This proposed method identified the latent dynamic patterns associated with different molecular subtypes, and radiomics analysis based on the pixel compositions of the uncovered dynamic patterns was able to determine molecular subtypes of breast cancer.

MDA-CF: Predicting MiRNA-Disease associations based on a cascade forest model by fusing multi-source information

MicroRNAs (miRNAs) are significant regulators in various biological processes. They may become promising biomarkers or therapeutic targets, which provide a new perspective in diagnosis and treatment of multiple diseases. Since the experimental methods are always costly and resource-consuming, prediction of disease-related miRNAs using computational methods is in great need. In this study, we developed MDA-CF to identify underlying miRNA-disease associations based on a cascade forest model. In this method, multi-source information was integrated to represent miRNAs and diseases comprehensively, and the autoencoder was utilized for dimension reduction to obtain the optimal feature space. The cascade forest model was then employed for miRNA-disease association prediction. As a result, the average AUC of MDA-CF was 0.9464 on HMDD v3.2 in five-fold cross-validation. Compared with previous computational methods, MDA-CF performed better on HMDD v2.0 with an average AUC of 0.9258. Moreover, MDA-CF was implemented to investigate colon neoplasm, breast neoplasm, and gastric neoplasm, and 100%, 86%, 88% of the top 50 potential miRNAs were validated by authoritative databases. In conclusion, MDA-CF appears to be a reliable method to uncover disease-associated miRNAs. The source code of MDA-CF is available at https://github.com/a1622108/MDA-CF.

MDA-GCNFTG: identifying miRNA-disease associations based on graph convolutional networks via graph sampling through the feature and topology graph

Accurate identification of the miRNA-disease associations (MDAs) helps to understand the etiology and mechanisms of various diseases. However, the experimental methods are costly and time-consuming. Thus, it is urgent to develop computational methods towards the prediction of MDAs. Based on the graph theory, the MDA prediction is regarded as a node classification task in the present study. To solve this task, we propose a novel method MDA-GCNFTG, which predicts MDAs based on Graph Convolutional Networks (GCNs) via graph sampling through the Feature and Topology Graph to improve the training efficiency and accuracy. This method models both the potential connections of feature space and the structural relationships of MDA data. The nodes of the graphs are represented by the disease semantic similarity, miRNA functional similarity and Gaussian interaction profile kernel similarity. Moreover, we considered six tasks simultaneously on the MDA prediction problem at the first time, which ensure that under both balanced and unbalanced sample distribution, MDA-GCNFTG can predict not only new MDAs but also new diseases without known related miRNAs and new miRNAs without known related diseases. The results of 5-fold cross-validation show that the MDA-GCNFTG method has achieved satisfactory performance on all six tasks and is significantly superior to the classic machine learning methods and the state-of-the-art MDA prediction methods. Moreover, the effectiveness of GCNs via the graph sampling strategy and the feature and topology graph in MDA-GCNFTG has also been demonstrated. More importantly, case studies for two diseases and three miRNAs are conducted and achieved satisfactory performance.